Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.
A Meta-Analysis of Intraepidermal Nerve Fibre Density in Healthy and Neuropathic Subjects: A Proposed Guidance Model
21 Pages Posted: 2 Jan 2019
More...Abstract
Background: Skin spot biopsy is the gold standard for diagnosis of small fibre neuropathy. Here we systematically approached intraepidermal nerve fibre density (IENFD) with the aim of precisely estimating its value in healthy and neuropathic subjects. The present findings will serve as a guidance model for further use of IENFD, as an indicator of neuropathy predisposition. We also investigated how IENFD was influenced by age, gender, and neuropathy.
Methods: We conducted a systematic search of PubMed, Web of Science, and ScienceDirect to identify clinical studies published during the last twenty years (1997-2017), which investigated IENFD in healthy and neuropathic adult population. Data were retrieved from longitudinal cohort studies including 5-188 healthy adult subjects and 6-40 neuropathic adult patients. We used meta-analysis techniques including multilevel meta-regression.
Findings: In the healthy population, the estimated (95% CI) IENFD values (in fibres/mm) were 21.4 (19.9, 22.9) in the thigh, 17*7 (15.3, 20.1) in the forearm, 12*9 (11.8, 14.0) in the distal leg, 11*3 (6.1, 16.5) in the fingers, and 6*5 (4.4, 8.6) in the toes. The corresponding estimates in the neuropathic population were 17*2 (15.2, 19.2) in the thigh, 6*3 (2.3, 10.2) in the forearm, 5*1 (3.8, 6.4) in the distal leg, and 2*0 (0.0, 5.7) in the toes. In the healthy population, IENFD decreased with ageing, by 1*4 fibres/mm every 5 years (p<0.001). We detected gender dimorphism in IENFD, with females showing higher IENFD values in the distal leg (13*6-10*5 fibres/mm) compared to males (9*3-7*2 fibres/mm).
Interpretation: The present meta-analysis results highlighted the IENFD alterations in neurodegenerative disease, suggesting that IENFD may be a reliable prognostic marker for the timely diagnosis of neuropathy.
Funding Statement: The authors state: "There was no funding source for this study."
Declaration of Interests: There is no conflict of interest.
Keywords: intraepidermal nerve fibre density, neuropathy, skin biopsy, small fibre neuropathy, healthy, meta-analysis
Suggested Citation: Suggested Citation